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Abstract
In this study, the effects of Baicalin on the hyperglycemia-induced cardiovascular malformation during embryo
development were investigated. Using early chick embryos, an optimal concentration of Baicalin (6 μM) was identiﬁed
which could prevent hyperglycemia-induced cardiovascular malformation of embryos. Hyperglycemia-enhanced cell
apoptosis was reduced in embryos and HUVECs in the presence of Baicalin. Hyperglycemia-induced excessive ROS
production was inhibited when Baicalin was administered. Analyses of SOD, GSH-Px, MQAE and GABAA suggested
Baicalin plays an antioxidant role in chick embryos possibly through suppression of outwardly rectifying Cl(−) in the
high-glucose microenvironment. In addition, hyperglycemia-enhanced autophagy fell in the presence of Baicalin,
through affecting the ubiquitin of p62 and accelerating autophagy ﬂux. Both Baicalin and Vitamin C could decrease
apoptosis, but CQ did not, suggesting autophagy to be a protective function on the cell survival. In mice, Baicalin
reduced the elevated blood glucose level caused by streptozotocin (STZ). Taken together, these data suggest that
hyperglycemia-induced embryonic cardiovascular malformation can be attenuated by Baicalin administration through
suppressing the excessive production of ROS and autophagy. Baicalin could be a potential candidate drug for women
suffering from gestational diabetes mellitus.
Introduction
Roots of Scutellaria baicalensis are used in Chinese
medicine and it reputedly calms fetuses in pregnant
women1,2. Baicalin, a ﬂavone glycoside (the glucuronide of
Baicalein), is formed via the binding of glucuronic acid with
Baicalein, in the roots of Scutellaria baicalensis and Scu-
tellaria lateriﬂora. Baicalin is principally used in Asian
countries as a herbal supplement because of its wide variety
of health beneﬁts, including anti-neuroinﬂammatory3, anti-
cancer4 and anti-anxiety effects5. It can also improve lung
function6 and fertility7.The most common mechanism of
Baicalin being against pathogenesis is its protective effect
by reducing the production of oxidative stress8. Interest-
ingly, Qi et al.9 reported that Baicalin could enhance the
developmental competence of mouse embryos through
suppressing cellular apoptosis and HSP70 expression, and
activating DNA methylation. However, whether or not
Baicalin can prevent malformation of the cardiovascular
system caused by environmental hazards at an early stage
remains unclear. This study focuses on the potential ben-
eﬁcial effects of Baicalin on the early development of heart
tube and vasculature, in order to explore whether or not
Baicalin could be a potential candidate drug for pregnant
women.
During embryonic development, the cardiovascular
system appears ﬁrst, since oxygen and nutrients need to
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be delivered to the tissues and waste products must be
removed through blood circulation as the embryo devel-
ops. The cardiovascular system is composed of heart and
blood vessels, including arteries, veins and capillaries in
the adult. Heart and vasculature derive from both the
embryonic mesoderm and extra-embryonic yolk sac.
During early embryonic development, the heart initially
forms in embryonic disc as a simple paired heart tube
inside the forming pericardial cavity. During the process,
the heart formation undergoes a series of transformations.
A straight heart tube derives from the fusion of bilateral
cardiomyocytes in primary/secondary heart ﬁelds at
embryonic midline10, and then followed by the right
looping of the heart tube and sepetation11. Endoderm-
derived signals such as bone morphogenetic protein
(BMP), ﬁbroblast growth factor and Wnt antagonist are
indispensable for precardiac mesoderm cells to differ-
entiate into mature cardiomyocytes during cardiomyo-
genesis12–14. Moreover, Nkx2.5 and GATA factors are all
considered to be the important cardiogenic transcription
factors that characterize and induce cardiogenic
differentiation15.
Meanwhile, vasculature formation occurs in embry-
ogenesis at three different morphological stages, including
vasculogenesis, angiogenesis and vascular remodeling.
Both vasculogenesis and angiogenesis are accomplished in
the prenatal period. Vasculogenesis depicts the formation
of initial primitive vascular plexus derived from heman-
gioblasts in extra-embryonic yolk sacs or within the
embryo. The earliest appearance is in blood islands
located in the extra-embryonic region, in which the
mesoderm contributes to blood islands and then these
cells differentiate into both the epithelium of blood vessels
and fetal red blood cells. Morphologically, these blood
islands join together to form the primary blood plexus
(vasculogenesis) that connects with the developing heart
tube to form the integrated cardiovascular system.
Angiogenesis involves the remodeling and expansion of
the vascular plexus through endothelial sprouting and
intussusceptive microvascular growth16. The yolk sac
membrane (YSM) in the extra-embryonic region is the
initial site where blood vessels and angioblasts develop,
and the physiological function of YSM is to provide
nutrition to the developing embryo. The chick chor-
ioallantoic membrane (CAM) is a highly vascularized
membrane underneath the inner surface of the eggshell,
and CAM is formed by the fusion of the chorionic
membrane and allantois during embryo development.
Both chick YSM and CAM are excellent in vivo models
for studying the angiogenesis because they can be easily
accessed and manipulated in vitro17–20.
Gestational diabetes is due to glucose intolerance dur-
ing pregnancy and presents as high blood glucose levels at
the beginning of pregnancy. The incidence of congenital
malformations in diabetic pregnancy has been reported to
be 2−5 times higher than in non-diabetic pregnancy21.
Dysplasia of the cardiovascular system during cardio-
genesis and angiogenesis leads to constantly impaired
fetal development or death. However, there is no effective
drug for the protection of embryonic development of
gestational diabetes mellitus. In our previous studies, early
gastrulating chick embryo was employed as an experi-
mental model in gestational diabetes-induced cardiovas-
cular malformation22,23. We found both reactive oxygen
species (ROS) and autophagy play an important role in
chick embryo malformation. In the present study, Baicalin
was shown to exhibit a protective effect on early cardio-
vascular development, and the underlying mechanisms
were partly dissected using in vivo chick and mouse
models, and HUVEC cell line.
Materials and methods
Mice and treatment
Reagents
Baicalin (99% purity) was purchased from Santa Cruz
Biotechnology (Dallas, TX, USA). According to the results
of Chen et al., 40 mg/kg body weight (BW) of Baicalin can
alleviate the effect of mifepristone on the levels of serum
estrogen/progesterone and the important molecules of
canonical Wnt signaling pathway during peri-
implantation period in mice24.
Experimental animal groups and treatments
Kunming mice were obtained from the Laboratory Ani-
mal Centre of Sun Yat-sen University (Guangzhou, China).
Diabetes mellitus was induced in 8-week-old female mice
by injecting streptozotocin (STZ; Sigma, St. Louis, MO,
USA; dissolved in 0.01mol/l citrate buffer, pH 4.5) at 75
mg/kg BW for three consecutive days. Blood glucose levels
were measured by the Roche Accu-Chek Aviva Blood
Glucose System (Roche, Penzberg, BY, Germany) for 7 days
after STZ injection. Diabetes mellitus was characterized as
non-fasting blood glucose level exceeding 16mM16,17.
Mice with diabetes mellitus were randomly divided into
two groups: a 40mg/kg BW Baicalin treatment group (n=
12) and a physiological saline treatment group (n= 11). In
control (n= 6) and diabetes mellitus groups, the mice were
administered with 0.1% dimethyl sulfoxide solution via an
intra-gastric gavage for 1 week. The mice in Baicalin group
were administered with 1ml/day of Baicalin by intra-
gastric gavage for 1 week.
This study was carried out in strict accordance with the
recommendations of the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
The protocol was approved by the Committee on the
Ethics of Animal Experiments of the Jinan University. All
surgeries were performed under pentobarbital anesthesia,
and all efforts were employed to minimize suffering.
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Avian embryos and treatment
Fertilized chick eggs were obtained from the Avian
Farm of the South China Agriculture University. The eggs
were incubated until the required stage25 in a humidiﬁed
incubator (Yiheng Instrument, Shanghai, China) at 38 °C
and 70% humidity. For early gastrula embryos, HH0
(Hamburger and Hamilton stage)25 chick embryos were
prepared and incubated in the absence/presence of Bai-
calin (Sigma, USA) and/or high glucose (Sigma, USA) and
Rapa (LC Labs, USA) using early chick culture (EC cul-
ture) as described previously26.
The embryos were harvested at the desired time based
on the experimental requirements after incubation at
38 oC. All of the embryos were photographed using a
stereomicroscope (Olympus MVX10, Japan) before being
ﬁxed with 4% paraformaldehyde for morphological and
gene expression analysis. Only the surviving embryos
were used for further study. For the histological analysis,
the treated embryos or yolk sacs were dehydrated,
embedded in parafﬁn wax and serially sectioned at 5 µm
using a microtome (Leica RM2126RT, Germany). The
sections were de-waxed in xylene, rehydrated and stained
with either hematoxylin and eosin dye or immuno-
ﬂuorescent stain, and photographed using a ﬂuorescent
microscope (Olympus IX50) with the NIS-Elements
F3.2 software package.
Assessment of angiogenesis on chick embryonic YSM
Brieﬂy, the eggs were treated with simple saline, 100 μl
of 3.75 mg/ml 2,2′-Azobis(2-methylpropionamidine)
dihydrochloride (AAPH) or/and 6 μM Baicalin per egg18.
The solutions were directly injected into the blunt air
chamber of the fertilized egg and then the embryos were
harvested after a further 4.5 days of incubation at 38 °C.
All of the harvested YSMs were photographed using a
stereomicroscope (Olympus MVX10, Tokyo, Japan)
before being used for molecular analyses.
Assessment of angiogenesis using chick CAM
As described previously27, chick embryos were incu-
bated until day 9 when the CAM was well developed.
The embryos were treated with 100 μl of simple saline,
high glucose (50 mM) and/or Baicalin (6 μM) for 48 h
and all surviving embryos were then harvested for
analysis. The CAM and accompanying blood vessels in
the control and high glucose (50 mM) and/or Baicalin
(6 μM)-treated embryos were photographed using a
Canon Powershot SX130 IS digital camera (12.1 M
Pixels).
Cell lines and culture
Human umbilical vascular endothelial cells (HUVECs),
a gift from Zhi Huang’s laboratory, were cultured in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) (Gibco,
Shanghai, China) supplemented with 10% fetal bovine
serum (FBS), and incubated at 37 °C and 5% CO2.
Histology
Brieﬂy, 12-week-old mouse livers, mouse kidney (con-
trol, STZ-induced-diabetes mellitus, and STZ-induced-
diabetes mellitus with Baicalin treatment) were ﬁxed in
4% paraformaldehyde at 4 °C for 24 h. The specimens
were then dehydrated, cleared in xylene and embedded in
parafﬁn wax. The embedded specimens were serially
sectioned at 5 μm using a rotary microtome (Leica,
RM2126RT, Wetzlar, Hessen, Germany). The sections
were stained with hematoxylin and eosin (H&E), periodic
acid Schiff (PAS) reaction, Masson’s trichrome dyes
(Masson staining), Sirius red or immunohistochemically.
The Masson and Sirius red stains were used to reveal the
presence of ﬁbrosis in liver sections and the histological
alterations of mice’s kidney. Photographs were captured
of the stained histological sections using an epi-
ﬂuorescence microscope (Olympus IX51, Leica DM
4000B).
Immunoﬂuorescent staining and F-actin/Hoechst/PI
staining
Chick embryos were harvested after a given time incu-
bation and ﬁxed in 4% PFA overnight at 4 °C. Whole-
mount embryo immunostaining was performed using the
following antibody: MF-20 (1:500, DSHB, USA). Brieﬂy,
the ﬁxed embryos were then incubated with this primary
antibody at 4 °C overnight on a shaker. Following exten-
sive washing, the embryos were incubated with anti-rabbit
IgG conjugated to Alexa Fluor 488 overnight at 4 °C on a
rocker. For F-actin detection, the cultured cells were
stained using phalloidin-Alexa-Fluor 488 (1:200, Invitro-
gen, USA) at room temperature for 2 h. All the embryos
were later counterstained with 4',6-diamidino-2-pheny-
lindole (DAPI; 1:1000, Invitrogen, USA) at room tem-
perature for 1 h. For Hoechst (1:1000, Sigma, USA)/
propidium iodide (PI, 1:1000, Sigma, USA) staining, the
cells were cultured and washed twice with cold
phosphate-buffered saline (PBS), and then incubated with
Hoechst/PI for 45 min at 37 °C in the dark.
Dihydroethidium and CCK8 assays
Dihydroethidium (DHE) staining was performed at the
end of cell culture using DHE ﬂuorescent probe (Beyo-
time, Shanghai, China) to detect the presence of super-
oxide anion (O2
−). The cells were incubated with 10 μM
DHE for 30min, at 37 °C, and then collected for analyses
according to the manufacturer’s instructions. HUVECs
(control, 6 μM Baicalin, 50 mM glucose and 6 μM Baicalin
+50mM glucose group) were seeded into 96-well plates.
These cells (1× 106 cells/ml) were maintained in DMEM
+10% fetal bovine serum at 37 °C and 5% CO2. The cell
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viability was assessed using CCK8 assay (cholecystokinin-
8). Brieﬂy, 10 μl of CCK8 reagent (Dojindo, Kumamoto,
Japan) was added to the 96-well plates and incubated
continually for 6, 12, 24 and 48 h at 37 °C. The absorbance
values were measured at 450 nm using a Bio-Rad model
450 microplate reader (Bio-Rad, Hercules, CA, USA). The
cell viability was indirectly determined by examining the
ratio of the absorbance value of Baicalin or/and glucose-
treated cells relative to the control cells, from this
experiments.
Western blot
Chick embryos (HH10) were collected and lysed with
CytoBuster™ Protein Extraction Reagent (#71009,
Novagen). The total protein concentration was deter-
mined using a BCA quantiﬁcation kit (BCA01, DingGuo
BioTECH, CHN). Samples containing equal amounts of
protein were resolved by odium dodecyl
sulfate–polyacrylamide gel electrophoresis and then
transferred to polyvinylidene diﬂuoride membranes (Bio-
Rad). The membranes were blocked with 5% Difco™
skimmed milk (BD) and then incubated with primary and
secondary antibodies. The antibodies used were GATA4
(Bioworld, USA); LC3B (Cell Signaling Technology, USA);
Beclin1 (Bioworld, USA); C-Caspase-3 (Cell Signaling
Technology, USA); p62 (Sigma, USA); β-actin (Pro-
teintech, USA); horseradish peroxidase-conjugated anti-
mouse IgG and anti-rabbit IgG (Cell Signaling Technol-
ogy, USA). All primary and secondary antibodies used
were diluted to 1:1000 and 1:2000 in 5% skimmed milk,
respectively. The protein bands of interest were visualized
using an ECL kit (#34079, Thermo Fischer Scientiﬁc Inc.,
USA) and GeneGnome5 (Syngene, UK). The staining
intensity of the bands was determined and analyzed using
Quantity One software (Bio-Rad).
In situ hybridization
Whole-mount in situ hybridization of chick embryos
was performed according to a standard in situ hybridi-
zation protocol28. Digoxigenin-labeled probes were syn-
thesized against VE-Cadherin21. The whole-mount
stained embryos were photographed by a stereomicro-
scope (Olympus MVX10, Tokyo, Japan).
RNA isolation and reverse transcription-PCR (RT-PCR)
Total RNA was isolated from HH10 chick embryos
using a Trizol kit (Invitrogen, USA) according to the
manufacturer’s instructions. First-strand complementary
DNA (cDNA) was synthesized to a ﬁnal volume of 25 μl
using SuperScript RIII ﬁrst-strand (Invitrogen, USA).
Following reverse transcription, PCR ampliﬁcation of the
cDNA was performed as described previously29,30. The
sets of primers used for RT-PCR are described in the
Supplementary Fig. 1. The PCR reactions were performed
in a Bio-Rad S1000TM Thermal cycler (Bio-Rad, USA).
The ﬁnal reaction volume was 50 μl, comprising 1 μl of
ﬁrst-strand cDNA, 25 μM forward primer, 25 μM reverse
primer, 10 μl PrimeSTARTM Buffer (Mg2+ plus), 4 μl
dNTP Mixture (TaKaRa, Japan), 0.5 μl PrimeSTARTM
HS DNA Polymerase (2.5 U/μl TaKaRa, Japan) and
RNase-free water. cDNA was ampliﬁed for 30 cycles. One
round of ampliﬁcation was performed at 94 °C for 30 s
and then 30 s at 58 °C and 30 s at 72 °C. The PCR products
(20 μl) were resolved using 1% agarose gels (Biowest,
Spain) in 1× TAE buffer (0.04M Trisacetate and 0.001M
EDTA) and 10,000× GeneGreen Nucleic Acid Dye
(TIANGEN, China) solution. The resolved products were
visualized using a transilluminator (SYNGENE, UK), and
photographs captured using a computer-assisted gel
documentation system (SYNGENE). Each of these
experiments was replicated at least three times.
RNA isolation and quantitative PCR
Total RNA was isolated from chick embryo (HH7 and
HH10) HUVECs using a Trizol kit (Invitrogen, USA)
according to the manufacturer’s instructions. First-strand
cDNA was synthesized to a ﬁnal volume of 20 μl using
iScriptTM cDNA Synthesis Kit (Bio-Rad, USA). Following
reverse transcription, PCR ampliﬁcation of the cDNA was
performed as described previously29,30. SYBR® Green
qPCR assays were then performed using a PrimeScriptTM
RT reagent kit (Takara, Japan). All speciﬁc primers used
are described in Supplementary Fig. 2. Reverse tran-
scription and ampliﬁcation reactions were performed in
Bio-Rad S1000TM (Bio-Rad, USA) and ABI 7000 thermal
cyclers, respectively. The housekeeping gene PPIA was
run in parallel to conﬁrm that equal amounts of RNA
were used in each reaction. The ratio between the
intensities of the ﬂuorescently stained bands corre-
sponding to genes and PPIA was calculated to quantify
the level of the transcripts for those gene mRNAs.
Quantitation of apoptotic cells
Annexin V-FITC (BD Bioscience, USA) and PI
double staining were used to identify and quantify
apoptotic cells present in the HUVECs (control,
50 mM glucose, 6 μM Baicalin, 6 μM Baicalin+50mM
glucose, 40 μg/ml Vitamin C+ 50mM glucose, 10 μM
chloroquine+50mM glucose treated for 48 h). Brieﬂy, the
cells were collected and resuspended in cold PBS at a
density of 1× 106 cells/ml and then introduced into 200
μl of the Annexin V-binding buffer. The samples were
then incubated with 2 μl ﬂuorescein isothiocyanate
(FITC)-labeled Annexin V and 2 μl PI at room tempera-
ture for 15min and immediately analyzed by a FACS
Calibur ﬂow cytometer (BD, NJ, USA). The acquired data
were evaluated using FCS-Express software version 3.0
(De Novo).
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Measurement of oxidative stress
Intracellular ROS was determined using a non-
ﬂuorescent dye DCF-DA (2′,7′-dichlorodihydroﬂuorescein
diacetate) (Sigma, USA), which is oxidized by ROS to the
ﬂuorescent dye DCF (2′,7′-dichloroﬂuorescin). The control
and high glucose (50mM) and/or Baicalin (6 μM)-treated
HUVECs were incubated in 10 μM DCF-DA for 20min.
Fluorescence was measured with a BD FACSAria (USA).
Superoxide dismutase (SOD), glutathione peroxidase
(GSH-Px) and malonicdialdehyde (MDA) are expressed in
the HH10 chick embryos. SOD, GSH-Px and MDA
activities were elucidated using commercial kits (Nanjing,
China). The results from control and the three treated
groups were analyzed based on the differences of their
respective ﬂuorescein decay curves.
Detection of intracellular chloride ion
Intracellular chloride ion concentration was measured
using N-[ethoxycar bonylmethyl]-6-methoxy-qu inolinium
bromide (MQAE) (Beyotime, China), a ﬂuorescent chloride
ion indicator. Upon binding halide ions such as chloride,
MQAE is quenched, resulting in a decrease in ﬂuorescence
without a shift in wavelength. HUVECs were incubated in
Krebs-HEPES buffer (PanEra, China) containing 5mM
MQAE at room temperature for 30min, and then washed
three times with Krebs-HEPES buffer. MQAE-loaded cells
(over 1× 105 cells) were then mounted on a glass coverslip
for 20min at room temperature.
Data analysis
The BVD in the CAM, YSM or blood island density was
analyzed using the Image Pro-Plus 5.0 software20. Statis-
tical analyses for all the experimental data generated were
performed using a SPSS 13.0 statistical package program
for Windows. The data were presented as mean± SD.
Statistical signiﬁcance were determined using paired Test,
independent samples T-test or one-way analysis of var-
iance. P< 0.05 was considered to be signiﬁcant.
Results
Screening the optimal concentration of Baicalin for
administration to early chick embryos
To determine whether or not there is a cytotoxic effect
on developing embryos following the application of Bai-
calin31, HH0 chick embryos were ﬁrst incubated with 3, 6,
12 and 24 μM Baicalin for 26, 39 and 48 h in EC culture
(Fig. 1a), respectively. The developing chick embryos
treated with sample saline (control) or various concentra-
tions (3, 6, 12 and 24 μM) of Baicalin were photographed at
incubation times of 0, 26, 39 and 48 h (Fig. 1b). Using
embryo length and somite pair number as the embryonic
developmental indices, 3 and 6 μM Baicalin showed no
effect, but exposure to 12 and 24 μM Baicalin signiﬁcantly
reduced length development (p< 0.05, p< 0.01, p< 0.001;
n> 6 embryos in each group) and somite pair numbers in
comparison to control embryos (p< 0.01, p< 0.001; n=
10; Fig. 1b1-b4). Meanwhile, it was observed that 3 μM and
6 μM Baicalin had no obvious effect on embryonic mal-
formation, but higher exposures of 12 and 24 μM had a
signiﬁcant effect (severe malformation: 33% in 12 μM and
50% 24 μM, n> 6 embryos in each group; Fig. 1c-c1).
Therefore, concentrations of 3 and 6 μM were used in
subsequent experiments.
Baicalin administration successfully reversed
hyperglycemia-inhibited development of early chick
embryos
Hyperglycemia has been shown to negatively affect
embryo development32. Here, through comparing the
development of gastrula chick embryos exposed to 50mM
glucose (high glucose (HG)) and/or 3 or 6 μM Baicalin for
26, 39 and 48 h (Fig. 2a), it was discovered that HG dra-
matically inhibited the length and somite pair numbers of
chick embryos (p< 0.001; n> 6 embryos in each group).
However, the addition of 6 μM Baicalin could signiﬁcantly
reverse the inhibitive effect on embryo development in 48
h (p< 0.001 compared with the HG group; n> 6 embryos
in each group; Fig. 2a1-b). Simultaneously, the numbers of
malformed embryos were also reduced to some degree
after addition of 6 μM Baicalin (severe malformation: 0%
in control, 50% in HG, 50% in HG+3 μM Baicalin and
20% in HG+6 μM Baicalin, n> 6 embryos in each group,
Fig. 2b). This indicates that Baicalin administration exerts
a positive effect on hyperglycemia-inhibited embryo
development.
Baicalin administration saved hyperglycemia-induced
malformation of early chick embryonic cardiovascular
system
Previous studies have shown that hyperglycemia could
enhance the risk of heart tube malformation during
embryogenesis22. MF-20 immunoﬂuorescent staining
showed that hyperglycemia induced a high incidence of
cardiac biﬁda (32%, Fig. 3c-c2,e) which was clearly sup-
pressed by addition of 6 μM Baicalin (16%, Fig. 3d-d2,e).
Normal C-loop heart tubes could only be observed in the
control and 6 μM Baicalin groups (100%, n= 25 in each
group, Fig. 3a-a2,b-b2,e). The RT-PCR data showed that
the expressions of heart tube formation-related genes,
including VMHC, N-Cadherin, Wnt3a and BMP2, were
down-regulated in the presence of HG (p< 0.01, p<
0.001), but VMHC, N-Cadherin, Wnt3a and BMP2
recovered to an extent following addition of 6 μM Baicalin
(p< 0.01, p< 0.001 compared to the HG group; Fig. 3f-f1).
A similar tendency was observed in the expression of
GATA4 as indicated by western blot data (p< 0.05
compared with the control group, p< 0.01 compared with
the HG group, Fig. 3g). Most of these genes were not
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changed signiﬁcantly in the Baicalin group compared with
the control group (p> 0.05).
Vasculogenesis starts from blood islands expressed in
VE-Cadherin, the blood island marker. VE-Cadherin
in situ hybridization in whole-mount HH8 chick
embryos (Fig. 4a) showed that blood island formation was
not affected by 6 μM Baicalin (p> 0.05, Fig. 4b-c,b1-c1,
b2-c2,f), was suppressed by 50 mM glucose (p< 0.001),
but the reduced blood islands increased again when Bai-
calin and glucose were applied together (p< 0.01 com-
pared with HG group, n= 8 in each group, Fig. 4d-e,d1-
e1,d2-e2,f). This suggests that Baicalin administration
could rescue the hyperglycemia-inhibited vasculogenesis
to some extent.
Furthermore, whether or not Baicalin administration
could rescue HG-inhibited angiogenesis23 was studied
using the chick CAM model, illustrated in Fig. S2A. Chick
embryo weight on the harvest day (day 9) was increased
slightly when exposed to 6 μM Baicalin (p> 0.05), and
reduced when exposed to 50mM glucose (p< 0.05), but
this reduction was reversed after exposure to 6 μM Bai-
calin (p< 0.01 compared with HG group, n> 10 embryos
in each group; Fig. S2B). Compared to the angiogenesis on
CAM in control group (p< 0.05, Fig. S2C), it was clear
that 6 μM Baicalin alone did not change the blood vessel
density (p> 0.05, Fig. S2D), and that 50 mM glucose
dramatically inhibited angiogenesis (p< 0.05, Fig. S2E).
The combination of 6 μM Baicalin and 50mM glucose
signiﬁcantly reversed the reduction of blood vessel density
induced by HG (p< 0.05 compared with HG group, n> 8
in each group; Fig. S2F). This is quantitatively analyzed in
Fig. S2G.
Fig. 1 The assessment of gastrula chick embryo development in the absence/presence of various concentrations of Baicalin. a The sketches
illustrating the EC culture of HH0 gastrula chick embryos in the absence/presence of Baicalin (see Materials and method section for details). b The
representative bright-ﬁeld images were taken from control (ﬁrst row), 3 μM Baicalin (second row), 6 μM Baicalin (third row), 12 μM Baicalin (fourth
row) and 24 μM Baicalin (ﬁfth row) groups at incubation times of 0, 26, 39 and 48 h, respectively. b1–b4 Bar charts showing the comparison of chick
embryo length at 26 h (b1), 39 h (b2), 48 h (b3) and somite pair numbers at 48 h (b4) in the absence/presence of various concentrations of Baicalin. c
The representative bright-ﬁeld images of normal (left) and abnormal (right) gastrula chick embryos after 48 h of incubation. c1 Bar chart showing the
comparison of normal and abnormal chick embryo numbers in the absence/presence of various concentrations of Baicalin.*p<0.05 compared with
control group; **p<0.01 compared with control group; ***p<0.001 compared with control group. Scale bars = 1000 µm in (b, c)
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In addition, the RT-PCR data showed that expressions
of vasculogenesis-related genes VEGF-R2 were down-
regulated in the presence of HG (p< 0.01), but there was a
partial recovery after addition of 6 μM Baicalin (p< 0.05
compared with HG group, Fig. 3g).
Baicalin administration rescued hyperglycemia-induced
cell proliferative reduction and apoptosis increase
Western blot data showed that the expression of
apoptosis-related gene C-caspase-3 increased in the pre-
sence of HG (p< 0.001), but was reversed to some extent
by addition of 6 μM Baicalin (p< 0.01 compared with HG
group, Fig. 5a) in early chick embryo. Furthermore,
HUVECs were incubated with 6 μM Baicalin/50 mM
glucose or in combination for 12, 24, 36 and 48 h. The cell
counting kit-8 (CCK8) was then used to detect cell pro-
liferation and viability (Fig. 5b). The results showed that
the HUVEC proliferation and viability dropped in the
presence of HG at 12, 24, 36 and 48 h of incubations (p<
0.001), but all of these reductions increased again when 6
μM Baicalin and 50mM glucose (p< 0.001 was added
together compared with HG group, n> 8 in each group;
Fig. 5b). The data from ﬂow cytometry showed that 50
mM glucose could signiﬁcantly enhance HUVEC apop-
tosis (p< 0.001), and this increased apoptosis induced by
HG was dramatically suppressed by the addition of 6 μM
Fig. 2 The assessment of gastrula chick embryo development in the absence/presence of HG and Baicalin. a The representative bright-ﬁeld
images were taken from control (ﬁrst row), 50 mM glucose + 0 μM Baicalin (second row), 50 mM glucose+3 μM Baicalin (third row) and 50mM
glucose+6 μM Baicalin (fourth row) groups at incubation times of 0, 26, 39 and 48 h, respectively. a1–a4Bar charts showing the comparison of chick
embryo length at 26 h (a1), 39 h (a2), 48 h (a3) and somite pair numbers at 48 h (a4) in the absence/presence of 50 mM glucose+various
concentrations of Baicalin. b Bar chart showing the comparison of severely abnormal chick embryo percentages in the absence/presence of various
concentrations of Baicalin. HG high glucose. ***p<0.001 compared with control group; #p<0.05 compared with HG group; ##p<0.01 compared with
HG group; ###p<0.001 compared with HG group. Scale bars = 1000 µm in (a)
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Baicalin (p< 0.05 compared with HG group, n= 3 in each
group, Fig. 5c-c1). Furthermore, using PI ﬂuorescent
staining, it could be demonstrated that 50 mM glucose
administration greatly increased the PI+ HUVEC num-
bers (p< 0.001), whereas HG-induced elevation of PI+
HUVEC numbers basically returned to normality (p<
0.001 compared with HG group, n= 3 in each group,
Fig. 5d-h,d1-g1). Meanwhile, the HUVEC shape outlined
by F-actin staining was observed to shrink in the presence
of 50 mM glucose (p< 0.001, n> 18 in each group,
Fig. 5d-h,d2-g2), and then it generally kept in size when
additional 6 μM Baicalin was added (p< 0.001 compared
to the HG group, n> 18 in each group, Fig. 5i).
Baicalin administration stabilized the hyperglycemia-
induced oxidative stresses’ secondary effect on
angiogenesis
The obviously excessive ROS production was dis-
covered in the presence of 50 mM glucose in HUVECs
in vitro culture (p< 0.001, n= 5 in each group), but the
addition of 6 μM Baicalin returned ROS levels back to
normal (p< 0.01 compared with HG group, Fig. 6a).
Fig. 3 The assessment of chick heart tube formation in the absence/presence of HG and Baicalin. a–d The representative MF-20
immunoﬂuorescent staining of chick heart tubes from control (a), 6 μM Baicalin (b), 50 mM glucose (c) and 6 μM Baicalin+50 mM glucose (d) group.
a1–d1 The transverse sections were taken from the levels indicated by dotted lines in (a–d), respectively. a2–d2 The sketches illustrating the shapes
of heart tubes at transverse sections in a1–d1 respectively. e Bar chart showing the comparison of the incidences in the absence/presence of HG or/
and Baicalin. f–f1 The RT-PCR data showing the expressions of VMHC, N-Cadherin, BMP2 and Wnt3a in HH10 chick embryos exposed to either simple
saline (control) or HG or/and Baicalin (f), which was quantitatively analyzed in (f1). g The western blot data showing the GATA4 expression in HH10
chick embryos exposed either simple saline (control) or HG or/and Baicalin (g), which was quantitatively analyzed in (g1). *p<0.05 compared with
control group; **p<0.01 compared with control group; ***p<0.001 compared with control group; ##p<0.01 compared with HG group; ###p<0.001
compared with HG group. Scale bars = 1000 µm in (a–d) and (a1–d1)
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Staining with DHE, the cell-permeable ﬂuorescent redox
indicator of superoxide, demonstrated that 50 mM glu-
cose administration in HUVECs could signiﬁcantly
increase the level of superoxide, but cotreatment with 6
μM Baicalin and 50mM glucose could restore the level of
superoxide (p< 0.05, Fig. 6b-b1). Additionally, the activ-
ities of SOD, MDA and GSH-Px were measured in HH10
chick embryos exposed to either Baicalin, glucose or in
combination. The results demonstrated that MDA activity
was distinctly elevated in the presence of 50 mM glucose
(p< 0.001, Fig. 6c), but dropped sharply after addition of
6 μM Baicalin (p< 0.001 compared with HG group, n= 3
in each group). There were no signiﬁcant alterations to
SOD activities when the embryos were exposed to HG (p
> 0.05, n= 8, Fig. 6d), but dropped signiﬁcantly when
treated with HG+Baicalin (p< 0.001, n= 8, Fig. 6d).
GSH-Px activity was elevated in the presence of 50 mM
glucose (p< 0.01 Fig. 6e), but the enzyme activities were
decreased following addition of 6 μM Baicalin in the
presence of 50 mM glucose (p< 0.001 compared with HG
group, n> 6 in each group, Fig. 6e). MQAE staining for
intracellular chloride ion concentration showed that there
more ﬂuorescent spots in the presence of HG, but were
partially recovered after the addition of 6 μM Baicalin in
HUVECs (Fig. S3, yellow arrows). Quantitative PCR data
showed that the expressions of GABAA were up-
regulated in the presence of HG (p< 0.01), but were
partially recovered after addition of 6 μM Baicalin in chick
embryos (p< 0.001 compared with HG group, n= 3,
Fig. 6f).
Next, the environment of excessive ROS level was
induced by the application of AAPH, a ROS generator, in
chick YSM. AAPH (3.75 mg/ml) treatment resulted in the
deaths of 13.40% of chick embryos as shown in Fig. 6g-g1,
but only 6.67% chick embryo deaths were found on
addition of 6 μM Baicalin after AAPH exposure (n= 30
embryos in each group). AAPH administration could
signiﬁcantly inhibit angiogenesis in YSM (p< 0.05),
whereas a lesser effect was obtained following combined
application of AAPH and Baicalin (p< 0.001, n> 7 in
each group, Fig. 6h-h1), suggesting that oxidative stress
could be one of the mechanisms underlying this protec-
tive effect on hyperglycemia-inhibited angiogenesis.
Baicalin administration redressed the hyperglycemia-
induced unbalanced secondary effect of autophagy on
heart tube formation
The western blot data showed that the ratio of LC3II/
LC3I, Beclin1 and p62 were highly expressed in the pre-
sence of 50 mM glucose (p< 0.05, p< 0.01), and that the
HG-enhanced expressions were suppressed in HH10
chick embryos by the administration of 6 μM Baicalin (p
Fig. 4 The assessment of blood island formation in the absence/presence of HG and Baicalin. a The sketches illustrating the EC culture of HH0
gastrula chick embryos in the absence/presence of HG or/and Baicalin. b–e Whole-mount in situ hybridization of VE-Cadherin was implemented on
the HH8 chick embryos exposed to sample saline (control) (b), 6 μM Baicalin (c), 50 mM glucose (d) and 6 μM Baicalin+50mM glucose (e). b1–e1 The
high magniﬁcation images were taken from the sites indicated by dotted squares in (b1–e1), respectively. b2–e2 The sketches illustrating the shapes
of blood islands in (b1–e1), respectively. f Bar chart showing the comparison of the blood island density on chick extra-embryonic regions in
absence/presence of HG or/and Baicalin. gThe RT-PCR data showing the expressions of VEGF-R2 in HH7 chick embryos exposed to either simple
saline (control) or HG or/and Baicalin. *p<0.05 compared with control group; **p<0.01 compared with control group; #p<0.05 compared with HG
group; ##p<0.01 compared with HG group. Scale bars = 1000 µm in (b–e) and 100 µm in (b1–e1)
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< 0.01, n= 3, Fig. 7a-a1). When Rapa was used to induce
autophagy in early gastrula chick embryos, 28% cardiac
biﬁda mortality of chick embryos was found (n= 25 in
each group, Fig. 7b–e) but this was reduced to 12% when
6 μM Baicalin was added.
To distinguish whether or not there are different roles
of oxidative stress and autophagy in hyperglycemia-
induced cardiovascular malformation, PI+ cell numbers
were determined and PI ﬂow cytometric assays conducted
in HUVECs in the presence of HG alone and together
with either Baicalin, Chloroquine (CQ) or Vitamin C (VC,
Fig. 8). The results indicate that HG signiﬁcantly elevated
cell PI+ cell numbers compared with control group (p<
0.001, n= 3 in each group. Fig. 8a-b1,f); the addition of
either 6 μM Baicalin or VC suppressed this elevation (p<
0.001 compared with HG group, n= 3. Fig. 8c-c1,e-e1,f).
However, the addition of CQ did not reduce the HG-
induced increase of cell PI+ cell numbers but were even
increased further (p> 0.05 compared with HG group,
Fig. 8d-d1,f). The ﬂow cytometry data showed that 50 mM
glucose could signiﬁcantly enhance HUVEC apoptosis (p
< 0.01, n= 3), and the increased apoptosis induced by HG
was dramatically suppressed by the addition of 6 μM
Baicalin or VC (p< 0.01, p< 0.05 compared with HG
Fig. 5 The extent of apoptosis in the absence/presence of HG and Baicalin. a The western blot data showing the C-caspase-3 expression in
HH10 chick embryos exposed with either simple saline (control) or HG or/and Baicalin. b Bar chart showing the comparison of CCK8 values of
HUVECs incubated with/without HG or/and Baicalin. c The propidium iodide (PI) ﬂow cytometric assay was implemented in 48-h incubated HUVECs
from control, 6 μM Baicalin, 50 mM glucose and 6 μM Baicalin+50 mM glucose group. c1 The bar chart showing the comparison of the values of B2
(late apoptosis)+B4 (early apoptosis) in the cultured HUVECs among control, 6 μM Baicalin, 50 mM glucose and 6 μM Baicalin+50 mM glucose group.
(d–g) The representative bright-ﬁeld images of 48-h cultured HUVECs from control (d), 6 μM Baicalin (e), 50 mM glucose (f) and 6 μM Baicalin+50mM
glucose (g) group. d1–g1 The ﬂuorescent staining of PI and Hoechst was implemented on 48-h cultured HUVECs as in (d–g), respectively. d2–g2 The
ﬂuorescent staining of F-actin and DAPI was implemented on 48-h cultured HUVECs as in (d–g), respectively. h Bar chart showing the cell surface
area of HUVECs in the absence/presence of HG or/and Baicalin. i Bar chart showing the ratio comparison between PI+ and Hoechst+ HUVECs in the
absence/presence of HG or/and Baicalin. *p<0.05 compared with control group; ***p<0.001 compared with control group; #p<0.05 compared with
HG group; ##p<0.01 compared with HG group; ###p<0.001 compared with HG group. Scale bars = 100 µm in (d–g1) and 50 µm in (d2–g2)
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group, n= 3, Fig. 8h-i,k-l). However, addition of CQ failed
to reduce the HG-induced apoptosis (p< 0.01 compared
with control group, Fig. 8j,l) and PI+ cell numbers were
again increased (p> 0.05 compared with HG group,
Fig. 8h,j,l).
Baicalin administration in pregnant mice could partially
suppress STZ-induced hyperglycemia
In order to examine whether the protective effect of
Baicalin is a consequence of modulating maternal blood
levels, pregnant STZ-induced diabetes mellitus mice
were treated as shown in Fig. 9a. The blood glucose
level was found to be signiﬁcantly increased after 3 days of
STZ injection, compared with the controls (second week:
p< 0.001, n= 25, Fig. 9b). Diabetic mice were then ran-
domly divided into two groups and one group was treated
with Baicalin for 10 days. Compared to the diabetic
controls, the blood glucose levels in the the group
receiving Baicalin by intra-gastric administration were
signiﬁcantly lower after 3 weeks (p< 0.01 compared with
Fig. 6 The redox homeostasis assessment in the absence/presence of HG and Baicalin. a Bar chart showing the comparisons of ROS
production among 48-h incubated HUVECs from control, 6 μM Baicalin, 50 mM glucose and 6 μM Baicalin+50mM glucose group. b Intracellular ROS
production was determined using DHE ﬂuorescent staining on the incubated HUVECs from control, 6 μM Baicalin, 50 mM glucose and 6 μM Baicalin
+50mM glucose group. b1 Bar chart showing the ratio comparisons of DHE+ cells and total DAPI+ cells among each group. c–e Bar charts showing
the comparisons of enzyme activities of SOD (c), MDA (d) and GSH-Px (e) among 48-h incubated HUVECs from control, 6 μM Baicalin, 50 mM glucose
and 6 μM Baicalin+ 50mM glucose group. f Quantitative PCR data showing the expressions of GABAA in chick embryos and HUVECs exposed to
either simple saline (control) or HG or/and Baicalin. g–g1 The representative images were photographed from 4.5-day YSM exposed to either sample
saline (control, left) or 3.75 mg/ml AAPH (right) (g), and the quantitatively analyzed embryo survival rates were shown in (g1). h–h1 The
representative images were photographed from 4.5-day YSM exposed to sample saline (control), 3.75 mg/ml AAPH, 6 μM Baicalin, and 6 μM Baicalin
+3.75mg/ml AAPH (h), and the quantitatively analyzed BDV (blood vessel density) was shown in (h1). *p<0.05 compared with control group;
**p<0.01 compared with control group; ***p<0.001 compared with control group; ##p<0.01 compared with HG group; ###p<0.001 compared with HG
group. Scale bars = 20 µm in (b) and 1000 µm in (f, g)
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the diabetes mellitus group, n= 11, 12, Fig. 9b). However,
there was no signiﬁcant difference at the 4–5-week stage.
The histologies of kidneys and livers were then examined
on the transverse sections. In comparison to the kidney
control, endothelium damage was observed (Fig. 9c2),
together with glomerular sclerosis (Fig. 9c5), hyperplasic
glomeruli mesangial cells (Fig. 9c5), thickening of
glomerular basement membrane (Fig. 9c8) as shown by
stars, but such kidney structure damage was much less
apparent in the mice receiving Baicalin (Fig. 9c3,c6,c9).
Increases of glomerular sclerosis (diabetes mellitus group
compared with control group: p< 0.001, Baicalin
administration group compared with diabetes mellitus
group: p< 0.01, Fig. 9d) and mesangial area (diabetes
mellitus group compared with control group: p< 0.001,
Baicalin administration group compared with diabetes
mellitus group: p< 0.01, Fig. 9e) showed that diabetes was
suppressed by Baicalin. Likewise, the degeneration and
necrosis of hepatocytes in the transverse section of dia-
betes mellitus mouse liver compared to control was dra-
matically improved after Baicalin administration (Fig. 9f).
These protective effects on kidney and liver might con-
tribute to lowering elevated blood glucose levels in dia-
betic mice.
Fig. 7 The assessment of autophagy in gastrula chick embryos and the incubated HUVECs in the absence/presence of Baicalin. a–a1
Western blot data showing the expressions of LC3I, LC3II, p62 and Beclin1 in the opaca area of HH10 chick embryos from control, 6 μM Baicalin, 50
mM glucose and 6 μM Baicalin+50mM glucose group (a), which was quantitatively analyzed in (a1). b–d The representative bright-ﬁeld images of
HH10 chick embryos exposed to sample saline (control) (b), Rapa (c) or Rapa+Baicalin (d). b1–d1 The MF-20 immunoﬂuorescent staining was
implemented in HH10 chick embryos exposed to sample saline (control) (b1), Rapa (c1) or Rapa+Baicalin (d1). b2–d2 The transverse sections at the
levels indicated by dotted lines in (b1–d1), respectively. e Bar chart showing the comparison of cardiac biﬁda incidences in HH10 chick embryos
exposed to sample saline (control), Rapa or Rapa+Baicalin. *p<0.05 compared with control group; **p<0.01 compared with control group; ##p<0.01
compared with HG group. Scale bars = 100 µm in (b–d), 10 µm in (b1–d1) and 100 µm in (g)
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Discussion
Baicalin is present as a glycoside in Scutellaria baica-
lensis Georgi, and is metabolized to its aglycone, Baicalein,
by the action of intestinal β-glucuronidase in the intes-
tine33. Signiﬁcantly, Baicalin can be reformed into Baica-
lein, which is its previous metabolism, in many tissues.
Both Baicalin and Baicalein can be detected in blood after
absorption in the intestine34. The roots of Scutellaria
baicalensis Georgi have been extensively used as tradi-
tional medicines in many East Asian countries to reduce
inﬂammation35. Earlier studies have shown Baicalin and
Baicalein to possess wide-ranging biological and phar-
macological functions, including anti-inﬂammation, anti-
cancer and anti-pruritic effects36–38. Most experiments
have been carried out in vitro only, which simpliﬁes the
scientiﬁc protocols but makes extrapolation to the in vivo
situation difﬁcult, if not impossible. Therefore, it is crucial
to conduct well-designed in vivo experiments to investi-
gate these compounds’ pharmacological and toxicological
effects. As one of the ﬁrst systems to develop in early
pregnancy, the cardiovascular system is undoubtedly
vulnerable to diabetes mellitus-induced hyperglycemia
exposure. Dysplasia of the cardiovascular system during
cardiogenesis and angiogenesis leads to constantly
impaired fetal development or death. Therefore, in this
study, the focus has been on whether Baicalin adminis-
tration could improve hyperglycemia-induced cardiovas-
cular dysplasia.
Most of the experiments in this study have been carried
out using chick embryos. The advantage of this model is
that chick embryos can grow outside of uterus. They can
thus be easily manipulated, and can be especially useful
for the study of effects on early embryo development in
EC culture or angiogenesis using YSM and CAM. The
chick embryo model allows direct monitoring of the
development of the embryos at any stage following the
experimental manipulation in either EC culture or
windowed eggshell39. Song et al.40 reported the potential
embryotoxicity of Baicalin when they evaluated the safety
of Shuanghuanglian injection powder, in which Baicalin is
the main component, through placental barriers of rats.
The placental permeability of Baicalin undoubtedly
enables it to adversely affect embryonal development after
early embryo exposure.
For this reason, embryotoxic experiments were initially
conducted. Using the EC culture approach, an optimal
concentration of Baicalin was selected for administration
in subsequent experiments that did not inﬂuence chick
embryo development (Fig. 1). At the same time,
hyperglycemia-inhibited embryo development was
Fig. 8 The apoptosis assessment of HUVECs in the absence/presence of HG and Baicalin, chloroquine or Vitamin C. a–e The representative
bright-ﬁeld images of 48-h cultured HUVECs from control (a), 50 mM glucose (b), 6 μM Baicalin+50 mM glucose (c), 10 μM chloroquine (CQ)+50mM
glucose (d) and 40 μM Vitamin C+50mM glucose (e) group. a1–e1 The ﬂuorescent staining of PI and Hoechst was implemented on 48-h cultured
HUVECs as in (a–e), respectively. f Bar chart showing the ratio comparison between PI+ and Hoechst+ HUVECs in each group. g–k The PI ﬂow
cytometric assay was implemented in mentioned-above groups. l The bar chart showing the comparison of the values of Q2 (late apoptosis)+Q4
(early apoptosis) in the cultured HUVECs among mentioned-above groups. **p<0.01 compared with control group; ***p<0.001 compared with
control group; #p<0.05 compared with HG group; ##p<0.01 compared with HG group; ###p<0.001 compared with HG group. Scale bars = 100 µm in
(a–e) and (a1–e1)
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signiﬁcantly attenuated (Fig. 2). In the process of heart
tube formation, Baicalin administration could distinctly
reduce the risk of hyperglycemia-induced cardiac biﬁda by
reversing the expressions of the crucial genes related to
heart tube development (Fig. 3). In evaluating the effect of
Baicalin on vasculature development, the blood island
formation model (vasculogenesis) in area opaca and the
CAM model (angiogenesis), which include early stage of
blood islands/primary vessel plexus (Fig. 4), were
employed along with the later stage of angiogenesis (Fig.
S2). Obviously, the inhibitive effect of hyperglycemia on
blood island formation was greatly reduced in the pre-
sence of Baicalin (Fig. 4), while hyperglycemia-induced
angiodysplasia on CAM was also minimized by Baicalin
administration (Fig. S2). Taken together, these data sug-
gest that Baicalin administration has a positive impact on
hyperglycemia-induced cardiovascular dysplasia during
early embryo development.
Hyperglycemic conditions can increase both apoptotic
cell death and intracellular ROS generation41,42. There-
fore, an investigation of whether apoptosis is a key link for
Baicalin against hyperglycemia-induced cardiovascular
Fig. 9 The blood glucose and histological alterations in STZ-induced diabetes mouse models following administration of Baicalin. a The
sketches illustrating the mouse model of diabetes mellitus using STZ injection and Baicalin administration through intra-gastric administration and so
on. b The blood glucose level in the treated mice was detected in control, diabetes mellitus and diabetes mellitus+Baicalin groups at weeks 1–5. c
The representative H&E- and PAS-stained transverse sections of mouse kidneys from above three groups. d–e The bar charts showing the number
comparison of glomerular sclerosis (d) and among control, diabetes mellitus, and diabetes mellitus+Baicalin groups. f The representative H&E (upper)
or Masson (lower)-stained transverse sections of mouse livers from above three groups. ***p<0.001 compared with control group; ##p<0.01
compared with diabetes mellitus group. Scale bars = 100 µm in (c, f)
Wang et al. Cell Death and Disease  (2018) 9:234 Page 14 of 17
Ofﬁcial journal of the Cell Death Differentiation Association
malformation was carried out. Cell apoptosis induced by
hyperglycemic conditions was dramatically reversed by
Baicalin administration (Fig. 5). SOD, GSH-Px and MDA
were all decreased after addition of Baicalin to HG-treated
chick embryos (Fig. 6c-e). This suggested that Baicalin
might also play an antioxidant role in chick embryos, but
not through activating SOD and GSH-Px. Cell size was
reduced after HG exposure (Fig. 5i). The loss of cell
volume or cell shrinkage is a known morphological hall-
mark of apoptosis43,44. Activation of the volume-sensitive
outwardly rectifying Cl(−) channel is involved in this
process45. Detection of intracellular chloride ion showed a
reduction of Cl(−) in the presence of HG and that can be
reversed by the addition of Baicalin (Fig. S3). GABAA, an
important Cl(−) channel, is sensitive to ROS and recent
studies have demonstrated that Baicalin is acting through
GABAA5. The changes of GABAA shown here (Fig. 6f)
suggested that the antioxidant function of Baicalin is
caused by suppression of outwardly rectifying Cl(−) in the
HG microenvironment. Meanwhile, both the in vivo and
in vitro experiments imply that the hyperglycemia-
induced angiodysplasia could be partially rectiﬁed
through suppressing excessive ROS production induced
by HG (Fig. 6g,h). These observations further conﬁrm the
antioxidant bioactivity of Baicalin8,46.
Autophagy has been shown to be involved in high
glucose-induced heart tube malformation22. As in ear-
lier reports47,48 high glucose was observed to increase
the expression of p62, suggesting that autophagy ﬂux is
inhibited. However, after Baicalin was added, the
expression of the hyperglycemia-enhanced autophagy
gene decreased and cardiac biﬁda induced by Rapa-
induced excessive autophagy disappeared (Fig. 7).
These results suggest that Baicalin might increase the
ubiquitin of p62 and hence accelerate autophagy ﬂux.
These processes could facilitate the cleanup of damaged
Fig. 10 Model depicting how Baicalin administration improves HG-induced malformation of embryonic cardiovascular system. Being one
of the earliest developmental systems, the cardiovascular system is undoubtedly vulnerable to diabetes mellitus-induced hyperglycemia exposure in
early pregnancy. Dysplasia of the cardiovascular system during cardiogenesis and angiogenesis leads to constantly impaired fetal development or
death. However, there is no effective drug for the protection of embryonic development of gestational diabetes mellitus. Both Glucose and Baicalin
could transfer through placental barriers and then expose to the embryo. Therefore, in this study, the focus has been on whether Baicalin
administration could improve hyperglycemia-induced cardiovascular dysplasia in chick embryo. We found that Baicalin protects cardiovascular
formation from HG-induced damage through two mechanisms: (1) reducing hyperglycemia-enhanced excessive ROS generation might involve
suppression of outwardly rectifying Cl(−) and subsequent cell apoptosis; (2) promoting autophagy ﬂow through regulating the p62 to maintain the
intracellular homeostasis. Therefore, Baicalin could be a potential candidate drug for gestational diabetes mellitus women
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organelles. In order to examine this further and deter-
mine correlations between oxidative stress and autop-
hagy, the effect of Baicalin on cell apoptosis was studied
following addition of either Baicalin or CQ (blocking
autophagy) or Vitamin C (antioxidant) under HG con-
ditions. As Baicalin administration attenuated cell
apoptosis, suppressing ROS excessive production with
Vitamin C could reduce the cell apoptosis, but attempts
to block autophagy with CQ had no effect (Fig. 8). This
suggests that massive ROS-induced cell autophagy
plays an important role in cell apoptosis and that
autophagy should exert a protective function on cell
survival.
In consideration of maternal factors during application
of Baicalin, STZ-induced diabetes mellitus mice were
administered the compound. The results showed that
Baicalin administration could attenuate diabetes mellitus-
induced damage of kidney and liver to some extent; and
successfully reduce the blood glucose levels of diabetic
mice induced by STZ (Fig. 9) over the following weeks.
In summary (Fig. 10), Baicalin administration in mice
could partially confront maternal hyperglycemia. Mean-
while, Baicalin could cross the placental barrier to protect
cardiovascular formation from HG-induced damage. The
exact mechanisms involved in reducing hyperglycemia-
enhanced excessive ROS generation might involve sup-
pression of outwardly rectifying Cl(−); unbalanced
autophagy through regulating the p62 and subsequent cell
apoptosis mainly induced by ROS. Therefore, embryonic
angiodysplasia and heart tube malformation induced by
hyperglycemia could be partially reduced through the
intracellular homeostasis resulting from Baicalin admin-
istration, and Baicalin could be a potential candidate drug
for gestational diabetes mellitus women. Further experi-
mentations are required to investigate the therapeutic
potential in treatment of diabetes and to determine the
precise molecular mechanisms involved.
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